Invenra, Inc.

Invenra is developing next generation, multispecific antibody therapeutics based on our high-performance B-Body® Platform. With an initial focus in oncology, we and our partners are currently advancing pipelines of novel bi- and multispecific antibody candidates. With our growing portfolio of innovative therapeutic approaches and best in class clinical antibody screening and development platform, we intend to expand our pipeline across additional disease categories, creatively optimizing candidates to address even the most challenging of therapeutic targets.